Log in to save to my catalogue

Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case S...

Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case S...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ee13f543885c4b3fb5fece6acc392336

Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case Study for Nifedipine Minitablets

About this item

Full title

Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case Study for Nifedipine Minitablets

Publisher

Basel: MDPI AG

Journal title

Pharmaceutics, 2021-09, Vol.13 (10), p.1583

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Fuse deposition modelling (FDM) has emerged as a novel technology for manufacturing 3D printed medicines. However, it is a two-step process requiring the fabrication of filaments using a hot melt extruder with suitable properties prior to printing taking place, which can be a rate-limiting step in its application into clinical practice. Direct powd...

Alternative Titles

Full title

Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case Study for Nifedipine Minitablets

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ee13f543885c4b3fb5fece6acc392336

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ee13f543885c4b3fb5fece6acc392336

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics13101583

How to access this item